Skip to main content
Retour
Watch Compare

Emmaus Life Sciences, Inc.

Qualité des données : 100%
EMMA
OTC Manufacturing Chemicals
0,01 €
▼ 0,01 € (-33,33%)
Cap. Boursière: 701 982,0
Prix
0,01 €
Cap. Boursière
701 982,0
Fourchette du Jour
0,01 € — 0,01 €
Fourchette 52 Semaines
0,01 € — 0,02 €
Volume
70 000
Ouverture 0,01 €
Moyenne 50J / 200J
0,01 €
31,03% below
Moyenne 50J / 200J
0,01 €
21,88% below

Quick Summary

Points Clés

Revenue declined -11,83% annually over 5 years
Negative free cash flow of -12 000,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,39%
Capital efficient — spends only 0,01% of revenue on capex
Interest coverage of 0,03× — tight debt servicing

Croissance

Revenue Growth (5Y)
-11,83%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-25,22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-60,16%
Op. Margin1,85%

Sécurité

Debt / Equity
N/A
Current Ratio0,07
Interest Coverage0,03

Valorisation

PE (TTM)
-0,09
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDA109,18
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,1 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -60,2 -41,5
Rev Growth 5Y % -11,8 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -25,22% Revenue Growth (3Y) -35,13%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -11,83% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 12,45 M Net Income (TTM) -7,49 M
ROE N/A ROA -33,98%
Gross Margin 93,12% Operating Margin 1,85%
Net Margin -60,16% Free Cash Flow (TTM) -12 000,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,07
Interest Coverage 0,03 Asset Turnover 0,56
Working Capital -59,38 M Tangible Book Value -59,49 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,09 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 109,18 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1,71%
Market Cap 701 982,0 Enterprise Value 29,48 M
Per Share
EPS (Diluted TTM) -0,12 Revenue / Share 0,18
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,01% FCF Conversion 0,16%
SBC-Adj. FCF -58 000 Growth Momentum -13,39

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 12,45 M 16,65 M 29,60 M 18,39 M 20,61 M
Net Income -7,49 M -6,45 M -3,73 M -10,63 M -15,95 M
EPS (Diluted) -0,12 -0,10 -0,07 -0,21 —
Gross Profit 11,60 M 15,45 M 28,26 M 15,80 M 17,30 M
Operating Income 231 000,0 -1,89 M 3,54 M -6,59 M -6,13 M
EBITDA — — — — —
R&D Expenses 313 000,0 657 000,0 1,19 M 1,73 M 4,11 M
SG&A Expenses — — — — —
D&A 39 000,0 22 000,0 32 000,0 53 000,0 59 000,0
Interest Expense 7,13 M 5,49 M 7,38 M 5,01 M 3,10 M
Income Tax 9 000,0 29 000,0 -59 000,0 60 000,0 25 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 21,44 M 23,60 M 35,18 M 48,23 M 56,73 M
Total Liabilities 85,04 M 80,08 M 82,94 M 82,32 M 78,18 M
Shareholders' Equity -63,61 M -56,48 M -47,76 M -34,09 M -21,45 M
Total Debt 27,13 M 28,97 M 30,56 M 30,42 M 22,34 M
Cash & Equivalents 2,13 M 1,39 M 2,55 M 2,02 M 2,28 M
Current Assets 7,75 M 6,77 M 11,51 M 6,29 M 9,09 M
Current Liabilities 69,07 M 63,56 M 61,51 M 54,32 M 37,10 M